These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25628307)

  • 1. Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.
    Madsen TE; Khoury JC; Alwell KA; Moomaw CJ; Kissela BM; De Los Rios La Rosa F; Woo D; Adeoye O; Flaherty ML; Khatri P; Ferioli S; Kleindorfer D
    Stroke; 2015 Mar; 46(3):717-21. PubMed ID: 25628307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.
    Fredwall M; Sternberg S; Blackhurst D; Lee A; Leacock R; Nathaniel TI
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2569-2574. PubMed ID: 27618196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke.
    Boehme AK; Siegler JE; Mullen MT; Albright KC; Lyerly MJ; Monlezun DJ; Jones EM; Tanner R; Gonzales NR; Beasley TM; Grotta JC; Savitz SI; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e255-61. PubMed ID: 24468069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke.
    Cronin CA; Sheth KN; Zhao X; Messé SR; Olson DM; Hernandez AF; Bhatt DL; Schwamm LH; Smith EE
    Stroke; 2014 Sep; 45(9):2745-9. PubMed ID: 25104846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Age and Sex on Clinical Outcome after Intravenous Recombinant Tissue Plasminogen Activator Treatment in Patients with Acute Ischemic Stroke.
    Buijs JE; Uyttenboogaart M; Brouns R; de Keyser J; Kamphuisen PW; Luijckx GJ
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):312-6. PubMed ID: 26527412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community implementation of intravenous thrombolysis for acute ischemic stroke in the 3- to 4.5-hour window.
    Montaño A; Staff I; McCullough LD; Fortunato G
    Am J Emerg Med; 2013 Dec; 31(12):1707-9. PubMed ID: 24060324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
    Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
    Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
    Demaerschalk BM; Kleindorfer DO; Adeoye OM; Demchuk AM; Fugate JE; Grotta JC; Khalessi AA; Levy EI; Palesch YY; Prabhakaran S; Saposnik G; Saver JL; Smith EE;
    Stroke; 2016 Feb; 47(2):581-641. PubMed ID: 26696642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke.
    Savitz SI; Schlaug G; Caplan L; Selim M
    Stroke; 2005 Jul; 36(7):1447-51. PubMed ID: 15947268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial.
    de Los Ríos la Rosa F; Khoury J; Kissela BM; Flaherty ML; Alwell K; Moomaw CJ; Khatri P; Adeoye O; Woo D; Ferioli S; Kleindorfer DO
    Stroke; 2012 Jun; 43(6):1591-5. PubMed ID: 22442174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and Time to Arrival among Ischemic Stroke Patients in the Greater Cincinnati/Northern Kentucky Stroke Study.
    Madsen TE; Sucharew H; Katz B; Alwell KA; Moomaw CJ; Kissela BM; Flaherty ML; Woo D; Khatri P; Ferioli S; Mackey J; Martini S; De Los Rios La Rosa F; Kleindorfer D
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):504-10. PubMed ID: 26617327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
    You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
    Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially Missed Diagnosis of Ischemic Stroke in the Emergency Department in the Greater Cincinnati/Northern Kentucky Stroke Study.
    Madsen TE; Khoury J; Cadena R; Adeoye O; Alwell KA; Moomaw CJ; McDonough E; Flaherty ML; Ferioli S; Woo D; Khatri P; Broderick JP; Kissela BM; Kleindorfer D
    Acad Emerg Med; 2016 Oct; 23(10):1128-1135. PubMed ID: 27313141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.